The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Clinical advances include positive data with targeted therapies for HER2 exon 20 mutant lung cancer, for older patients with mantle cell lymphoma...
Latest News
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments at...
SAN DIEGO, CA ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This...
HOUSTON, TX ― The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of...
SAN DIEGO, Calif. – Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2024 show promising initial data for patients with lymphoma, gastric or gastroesophageal junction cancers, and specific molecularly selected tumors. The...
NEW YORK – The Muscular Dystrophy Association (MDA) has selected Keisha Greaves from Cambridge, Massachusetts, to represent families living with muscular dystrophy and related neuromuscular diseases alongside current National Ambassador eleven-year-old Ethan LyBrand of Decatur, Alabama. “I have been involved with MDA because muscular dystrophy is now a part of me,” said Keisha. “I feel like it is...
BUFFALO, NY – A new research paper was published in Genes & Cancer entitled, “Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis.” Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer worldwide but is often diagnosed at...
ISTANBUL — Zeynep Liva Elmacı, a dystonia patient who has been having uncontrollable involuntary contractions in her legs and arms for the last 5 years, underwent brain pacemaker surgery while awake by watching cartoons. The patient’s surgery was performed Medical Park, Turkey’s health power with 27 Hospitals and thousands of...
Charleston, SC – As the years add up, it’s common to notice slight changes in our ability to remember and think. Older people who have more marked changes than their peers can be diagnosed with mild cognitive impairment (MCI). Currently, we can’t easily predict which of these patients will develop...
TORONTO, Canada and HOUSTON, TX — Medicenna Therapeutics Corp., a clinical-stage immunotherapy company focused on the development of Superkines, today announced initiation of enrollment in the combination arm of the Phase 1/2 ABILITY (ABeta-only IL-2 ImmunoTherapY) study evaluating MDNA11, a long-acting, “beta-enhanced not-alpha” interleukin-2 (IL-2) super-agonist, with Merck’s pembrolizumab (KEYTRUDA®)....